期刊文献+

辛伐他汀在高血压治疗中的作用

The Role of Simvastatin in the Treatment of Hypertension
下载PDF
导出
摘要 目的:探讨辛伐他汀在高血压治疗中的作用。方法:选取2018年9月~2019年6月收治的132例高血压患者,按治疗方案不同分为对照组和研究组,各66例。对照组给予福辛普利治疗,研究组在对照组基础上接受辛伐他汀治疗。比较两组治疗效果,治疗前后血压(舒张压、收缩压)、血脂水平(总胆固醇、低密度脂蛋白胆固醇、三酰甘油)、血清C反应蛋白及不良反应发生情况。结果:研究组治疗总有效率为92.42%(61/66),高于对照组的78.79%(52/66)(P<0.05)。治疗后研究组舒张压、收缩压、总胆固醇、低密度脂蛋白胆固醇、三酰甘油、血清C反应蛋白水平均低于对照组(P<0.05)。两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论:在福辛普利基础上加用辛伐他汀治疗高血压效果确切,可有效调节血压、血脂,降低血清C反应蛋白水平,且不增加不良反应。
作者 冯丽芳 FENG Li-fang
出处 《实用中西医结合临床》 2021年第3期8-9,共2页 Practical Clinical Journal of Integrated Traditional Chinese and Western Medicine
  • 相关文献

参考文献6

二级参考文献58

  • 1刘力生.中国高血压防治指南2010[J].中国医学前沿杂志(电子版),2011,3(5):42-93. 被引量:1228
  • 2Atlas SA. The renin-angiotensin aldosterone system: pathophysiological role and pharmacologic inhibition. J Manag Care Pharm. 2007, 13(8 Suppl B):9-20.
  • 3Michel JB, Heudes D, Michel O, et al. Effect of chronic ANG I-converting enzyme inhibition on aging processes. II. Large arteries. Am JPhysioL 1994,267(1 Pt 2):R124-135.
  • 4Muratani H, Kimura Y, Matsumura K, et al. Effect of chronic inhibition of angiotensin converting enzyme on baroreceptor reflex in essential hypertension. Clin Exp Hypertens A. 1988, 10 Suppl 1:391-398.
  • 5Tiryaki O, Usalan C, Buyukhatipoglu H. Effect of combined angiotensin-converting enzyme and aldosterone inhibition on plasma plasminogen activator inhibitor type 1 levels in chronic hypertensive patients. Nephrology (Carlton). 2010,15(2):2li-215.
  • 6Alderman MH, Ooi WL, Cohen H, et al. Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients. Am Jtlypertens. 1997, 10(1):1-8.
  • 7Bair TL, May HT, Prescott MF, et al. Association between baseline levels of plasma renin activity and risk of cardiovascular events. Journal of the American College o/" Cardiology. 2009, 53(10 Suppl A):A383.
  • 8Latini R, Masson S, Anand I, et al. The comparative prognostic value of plasma neurohormones at baseline in patients with heart failure enrolled in VaI-HeFT. European Heart Journal. 2004,25(4):292-299.
  • 9Masson, S.,Solomon, S., Angelici, L., et al. Plasma renin activity retains a strong prognostic value in patients with chronic HF, independent of ACE inhibitor or beta-blocker therapy. Data from the Valsartan Heart Failure (Val-HeFT).
  • 10Duke Evidence-based Practice Center. Angiotensin-convert- ing enzyme inhibitors (ACEIs), angiotensin II receptor an- tagonists (ARBs), and direct renin inhibitors for treating es- sential hypertension: an update[R]. Durham: Duke Evi- dence-based Practice Center, 2011. Comparative Effectiveness Review, Number 34: AHRQ Publication No. 11-EHC063-EF, June.

共引文献72

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部